These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19287181)

  • 1. Tripterygium wilfordii Hook F treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysis.
    Xu G; Tu W; Jiang D; Xu C
    Nephron Clin Pract; 2009; 111(4):c223-8. PubMed ID: 19287181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
    Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome.
    Wang XB; Dai EL; Xue GZ; Ma RL
    Medicine (Baltimore); 2018 Jul; 97(27):e11282. PubMed ID: 29979395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.
    Tao X; Cush JJ; Garret M; Lipsky PE
    J Rheumatol; 2001 Oct; 28(10):2160-7. PubMed ID: 11669150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis.
    Liu L; Zhao H; Sun X; Zheng Q; Luo Y; Ru Y; Zhang Y; Chen X; Zhu B; Yin C; Li B; Li X
    BMC Complement Altern Med; 2018 Aug; 18(1):243. PubMed ID: 30170584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center.
    Yang L; Wang Q; Hou Y; Zhao J; Li M; Xu D; Zeng X
    Clin Rheumatol; 2020 Mar; 39(3):813-821. PubMed ID: 31713733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on effect of Tripterygium wilfordii Hook. f. on uterin leiomyoma].
    Gao Y; Chen D
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jul; 35(7):430-2. PubMed ID: 11776193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fingerprint chromatogram analysis of extracts from the leaves of Tripterygium wilfordii Hook. F. by high performance liquid chromatography.
    Li K; Wang S
    J Sep Sci; 2005 May; 28(7):653-7. PubMed ID: 15912735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripterygium wilfordii Hook F combination therapy with methotrexate for rheumatoid arthritis: An updated meta-analysis.
    Luo Y; Hou X; Xi A; Luo M; Wang K; Xu Z
    J Ethnopharmacol; 2023 May; 307():116211. PubMed ID: 36706936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of Tripterygium wilfordii Hook F in the immunosuppressive treatment of IgA nephropathy.
    Chen YZ; Gao Q; Zhao XZ; Chen XM; Zhang F; Chen J; Xu CG; Sun LL; Mei CL
    Intern Med; 2010; 49(19):2049-55. PubMed ID: 20930429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis.
    Wang X; Zu Y; Huang L; Yu J; Zhao H; Wen C; Chen Z; Xu Z
    Life Sci; 2017 Feb; 171():45-50. PubMed ID: 28088452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripterygium wilfordii Hook F as Maintenance Treatment for Crohn's Disease.
    Sun J; Shen X; Dong J; Wang H; Zuo L; Zhao J; Zhu W; Li Y; Gong J; Li J
    Am J Med Sci; 2015 Nov; 350(5):345-51. PubMed ID: 26473333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripterygium wilfordii Hook. f. versus azathioprine for prevention of postoperative recurrence in patients with Crohn's disease: a randomized clinical trial.
    Zhu W; Li Y; Gong J; Zuo L; Zhang W; Cao L; Gu L; Guo Z; Li N; Li J
    Dig Liver Dis; 2015 Jan; 47(1):14-9. PubMed ID: 25445405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.
    Tao X; Cai JJ; Lipsky PE
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1305-12. PubMed ID: 7891348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.
    Wang HL; Jiang Q; Feng XH; Zhang HD; Ge L; Luo CG; Gong X; Li B
    BMC Complement Altern Med; 2016 Jul; 16():215. PubMed ID: 27411429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis.
    Canter PH; Lee HS; Ernst E
    Phytomedicine; 2006 May; 13(5):371-7. PubMed ID: 16487688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice.
    Luo D; Zuo Z; Zhao H; Tan Y; Xiao C
    Front Med; 2019 Oct; 13(5):556-563. PubMed ID: 30604167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis.
    Zhang X; Xia J; Jiang Y; Pisetsky DS; Smolen JS; Mu R; Dai S; Weinblatt ME; Kvien TK; Li J; Dörner T; Zhang Y; Lu L; Yang C; Yang P; Zhang Y; Xu C; Zhao Z; Lipsky PE
    J Autoimmun; 2024 Jan; 142():103148. PubMed ID: 37967495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the study of immunopharmacological effects and mechanisms of extracts of Tripterygium wilfordii Hook. f. in neuroimmunologic disorders].
    Pan XD; Chen XC
    Yao Xue Xue Bao; 2008 Dec; 43(12):1179-85. PubMed ID: 19244746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of Tripterygium wilfordii hook F versus acitretin in moderate to severe psoriasis vulgaris: a randomized clinical trial.
    Wu C; Jin HZ; Shu D; Li F; He CX; Qiao J; Yu XL; Zhang Y; He YB; Liu TJ
    Chin Med J (Engl); 2015 Feb; 128(4):443-9. PubMed ID: 25673443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.